Advanced Oncotherapy (LSE:AVO) Common Stock : £118.34 Mil (As of Jun. 2022)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy Common Stock?

Advanced Oncotherapy's quarterly common stock increased from Jun. 2021 (£87.46 Mil) to Dec. 2021 (£112.90 Mil) and increased from Dec. 2021 (£112.90 Mil) to Jun. 2022 (£118.34 Mil).

Advanced Oncotherapy's annual common stock increased from Dec. 2019 (£61.11 Mil) to Dec. 2020 (£83.36 Mil) and increased from Dec. 2020 (£83.36 Mil) to Dec. 2021 (£112.90 Mil).

Advanced Oncotherapy Common Stock Historical Data

The historical data trend for Advanced Oncotherapy's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Common Stock Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Common Stock

Get a 7-Day Free Trial

20.23

42.39

61.11

83.36

112.90

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Common Stock	Get a 7-Day Free Trial															76.59	83.36	87.46	112.90	118.34

Advanced Oncotherapy Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Advanced Oncotherapy (LSE:AVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.